Advertisement

Topics

ALPCO Diagnostics Company Profile

09:45 EDT 19th September 2017 | BioPortfolio


News Articles [1105 Associated News Articles listed on BioPortfolio]

ALPCO to Launch New Zonulin ELISAs and Therapeutic Drug Monitoring Assays for IBD at Digestive Disease Week®

Salem, NH, May 02, 2017 --(PR.com)-- ALPCO, a leading producer of research and clinical immunoassays, announced it will launch new gastrointestinal and inflammatory bowel disease (IBD) assays at Dige...

ALPCO Offering Demonstrations of STELLUX® Chemiluminescent Plate Reader at ADA's 77th Scientific Sessions

Salem, NH, June 07, 2017 --(PR.com)-- ALPCO, a leading producer of research and clinical immunoassays, announced it will offer demonstrations of its new STELLUX® Chemiluminescent Plate Reader at...

ALPCO to Highlight Assay Qualification Program at the AACC’s 69th Annual Scientific Meeting and Clinical Lab Expo

Salem, NH, July 25, 2017 --(PR.com)-- ALPCO, a leading producer of research and clinical immunoassays, announced it will feature a variety of products supported by its assay qualification program at ...

ALPCO and InSphero Collaborate at the ADA's 77th Scientific Sessions to Advance Metabolic Disease Research

Salem, NH, June 06, 2017 --(PR.com)-- ALPCO, a leading producer of research and clinical immunoassays, announced it will collaborate with InSphero, a supplier of 3D cell culture solutions, at the ADA...

ALPCO Diagnostics Medical Equipment Deals and Alliances Profile [Report Updated: 11072017] Prices from USD $250

SummaryALPCO Diagnostics ALPCO is a lifescience company that imports and distributes immunoassay based products. The company's products include immunoassays, chemiluminescent assays, flow cytometry re...

Co-Diagnostics, Synbiotics launch joint venture CoSara Diagnostics in India

Co-Diagnostics, a molecular diagnostics company that has a unique, proprietary platform for the development of diagnostic tests, officially announced the recent incorporation of CoSara Diagnostics, a ...

IPO nets $6.4mm for Co-Diagnostics

Molecular diagnostics start-up Co-Diagnostics Inc. netted $6.4mm through its initial public offering of 1.18mm common shares at $6 each on the Nasdaq.

Thermo Fisher Sales, Market Shares and Competitive Position by ProductUSA, Europe, Japan [Updated: 13062017] Prices from USD $4250

This unique market intelligence report from VPGMarketResearch provides information not available from any other published source. The report includes diagnostics sales and market share estimates by pr...

Drugs and Medications [20 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [A.M. Home Diagnostics Inc. dba Healthline]

Oxygen

Cystografin dilute diatrizoate meglumine injection usp 18% [Bracco Diagnostics Inc.]

CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%

Cystografin diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%

Multihance [Bracco Diagnostics Inc]

These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...

Reno-30 diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

RENO-30 Diatrizoate Meglumine Injection USP 30%

PubMed Articles [268 Associated PubMed Articles listed on BioPortfolio]

Component resolved diagnostics for hymenoptera venom allergy.

Component-resolved diagnostics makes use of defined allergen molecules to analyse IgE-mediated sensitizations at a molecular level. Here, we review recent studies on the use of component-resolved diag...

Exploring the Case for a Global Alliance for Medical Diagnostics Initiative.

In recent years, the private and public sectors have increased investments in medical diagnostics for low- and middle-income countries (LMICs). Despite these investments, numerous barriers prevent the...

Comprehensive genetic study of cystic fibrosis in Slovak patients in 25 years of genetic diagnostics.

Cystic fibrosis (CF) has one of the longest histories in hereditary disease molecular diagnostics. However, identification of causative mutations in the CFTR gene is complicated by over two thousand c...

Resistance diagnosis and the changing economics of antibiotic discovery.

Point-of-care diagnostics that can determine an infection's antibiotic sensitivity increase the profitability of new antibiotics that enjoy patent protection, even when such diagnostics reduce the qua...

Advances in point-of-care technologies for molecular diagnostics.

Advances in miniaturization, nanotechnology, and microfluidics, along with developments in cloud-connected point-of-care (POC) diagnostics technologies are pushing the frontiers of POC devices toward ...

Clinical Trials [156 Associated Clinical Trials listed on BioPortfolio]

ALPCO Calprotectin ELISA - Measurement of Calprotectin Levels in Human Stool

The ALPCO Calprotectin ELISA is an in vitro diagnostic test intended to quantitatively measure concentrations of fecal calprotectin in human stool samples. Calprotectin is a protein biomar...

Differential Diagnostics of Etiology of Acute Infections

Method for diagnostics of the origin of infections (bacterial vs viral) based on the identification of activation markers of blood neutrophils and monocytes will be developed.

Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study

With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobi...

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

The purpose of this study is to assess the performance of the HTLV Blot 2.4 from patients with the following conditions: infected with HTLV and neurological conditions with symptoms simila...

HIV Point-of-Care Test Evaluation in Infants

HIV Point-of-Care tests in Babies Study (BABY) - Operational evaluation of HIV Point-of-Care tests for very early infant HIV diagnostics in infants born to HIV infected mothers in Mbeya, T...

Companies [892 Associated Companies listed on BioPortfolio]

ALPCO Diagnostics

ALPCO

Sekisui Diagnostics

A Sekisui Chemical company since 2011, Sekisui Diagnostics is a leading supplier of high quality products to diagnostic manufacturers, clinical laboratories and physician offices ...

Innotrac Diagnostics Oy

Founded 1995Located in Turku, FinlandInnotrac Diagnostics provides health care professionals with a comprehensive immunoassay platform and test portfolio for rapid and high quality results in cardiac ...

Cleveland Diagnostics, Inc.

Cleveland Diagnostics, Inc., is a clinical-stage biotechnology company developing technology to improve cancer diagnostics. Its Solvent Interaction Analysis (SIA) technology inves...

More Information about "ALPCO Diagnostics" on BioPortfolio

We have published hundreds of ALPCO Diagnostics news stories on BioPortfolio along with dozens of ALPCO Diagnostics Clinical Trials and PubMed Articles about ALPCO Diagnostics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ALPCO Diagnostics Companies in our database. You can also find out about relevant ALPCO Diagnostics Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record